Distinctive effects of licarin A on lipolysis mediated by PKA and on formation of brown adipocytes from C3H10T1/2 mesenchymal stem cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoon, Dahyeon | - |
dc.contributor.author | Imran, Khan Mohammad | - |
dc.contributor.author | Kim, Yong-Sik | - |
dc.date.accessioned | 2021-08-11T12:43:43Z | - |
dc.date.available | 2021-08-11T12:43:43Z | - |
dc.date.issued | 2018-02-01 | - |
dc.identifier.issn | 0041-008X | - |
dc.identifier.issn | 1096-0333 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/6218 | - |
dc.description.abstract | Obesity increases with the positive energy imbalance and correlates with increased risks for metabolic diseases. Promotion of white adipose tissue beiging has received considerable attention due to possible usefulness for preventing obesity and the comorbidities. Licarin A (LA) is a compound derived from Mexican medicinal plant Aristolochia taliscana. Here, we report that LA stimulates the development of brown-like and beige-like adipocytes from C3H10T1/2 mesenchymal stem cells with phenotypic shifts to formation of smaller lipid droplets. LA also markedly induced the expression of proteins characteristic of brown-like adipocytes in C3H10T1/2 mesenchymal stem cells. LA induced uncoupling protein 1 (Ucp1) and expression of other thermogenic genes in C3H10T1/2 mesenchymal stem cells via a mechanism involving protein kinase A (PKA). LA treatment also inhibited expression of white-adipocyte specific genes. Moreover, LA treatment promoted lipolysis via PICA mediated pathway. Our findings inaugurate a new role of LA as an inducer of brown-like adipocytes formation with lipolytic properties, which in future might be studied in vivo as a potential anti-obesity agent. | - |
dc.format.extent | 12 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Academic Press | - |
dc.title | Distinctive effects of licarin A on lipolysis mediated by PKA and on formation of brown adipocytes from C3H10T1/2 mesenchymal stem cells | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1016/j.taap.2017.12.015 | - |
dc.identifier.scopusid | 2-s2.0-85039802722 | - |
dc.identifier.wosid | 000424317600002 | - |
dc.identifier.bibliographicCitation | Toxicology and Applied Pharmacology, v.340, pp 9 - 20 | - |
dc.citation.title | Toxicology and Applied Pharmacology | - |
dc.citation.volume | 340 | - |
dc.citation.startPage | 9 | - |
dc.citation.endPage | 20 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Toxicology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Toxicology | - |
dc.subject.keywordPlus | HORMONE-SENSITIVE LIPASE | - |
dc.subject.keywordPlus | ADIPOSE-TISSUE | - |
dc.subject.keywordPlus | INSULIN-RESISTANCE | - |
dc.subject.keywordPlus | FAT | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | DIFFERENTIATION | - |
dc.subject.keywordPlus | TRANSLOCATION | - |
dc.subject.keywordPlus | LINEAGE | - |
dc.subject.keywordPlus | PROTEIN | - |
dc.subject.keywordPlus | OBESITY | - |
dc.subject.keywordAuthor | C3H10T1/2 | - |
dc.subject.keywordAuthor | Licarin A | - |
dc.subject.keywordAuthor | Browning | - |
dc.subject.keywordAuthor | Ucp1 | - |
dc.subject.keywordAuthor | Protein kinase A | - |
dc.subject.keywordAuthor | Lipolysis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.